Aurélien Grosdidier

10.9k citations

23 papers · 6.6k indexed · 3 hit papers · h-index 21

Impact in

Computational Theory and Mathematics top 0.2%
- Computational Drug Discovery Methods
Biological Psychiatry top 2%

Papers in

Biological Psychiatry 2
Computational Theory and Mathematics 9
- Computational Drug Discovery Methods 9

Co-authors: Olivier Michielin Vincent Zoete Michel A. Cuendet Matthias Wirth David Gfeller Antoine Daina Hugues Lortat‐Jacob Anne Imberty
Journals: Journal of Computational Chemistry (4 papers)Journal of Biological Chemistry (4 papers)Journal of Medicinal Chemistry (2 papers)Nucleic Acids Research (2 papers)PLoS ONE (2 papers)
Partner nations: Switzerland France Belgium

In The Last Decade

Aurélien Grosdidier

23 papers receiving 6.5k citations

Hit Papers

align trajectories log scale

SwissTargetPrediction: a web server for target prediction of bioactive small molecules 2014 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Nucleic Acids Research
2011 Nucleic Acids Research
2011 Journal of Computational Chemistry

Peers

Replace Hai‐Bin Luo with:

Hai‐Bin Luo China

Xu Shen China

Edward H. Kerns United States

Asimul Islam India

Giulio Vistoli Italy

Giulio Rastelli Italy

Stefano Forli United States

Stanislav Gobec Slovenia

Stefano Alcaro Italy

Aurélien Grosdidier relative to Hai‐Bin Luo China Hai‐Bin Luo's profile →

Citations per field

00.5×1.5×2×2.3×

Hai‐Bin Luo · 1×

×1.9 1k/752

CTM

×2.3 214/92

BP

×1.7 545/321

PHARM

×1.1 4k/3k

MB

×0.5 655/1k

PHARM

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by Aurélien Grosdidier

Since Specialization

Citations

This map shows the geographic impact of Aurélien Grosdidier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Grosdidier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Grosdidier more than expected).

Fields of papers citing papers by Aurélien Grosdidier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélien Grosdidier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Grosdidier. The network helps show where Aurélien Grosdidier may publish in the future.

Co-authors

The 25 scholars most cited alongside Aurélien Grosdidier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aurélien Grosdidier Line = papers co-authored together Aurélien Grosdidier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SwissTargetPrediction: a web server for target prediction of bioactive small molecules Nucleic Acids Research ·David Gfeller, Aurélien Grosdidier, Matthias Wirth, Antoine Daina, Olivier Michielin, Vincent Zoete Hit paper breakdown →	2014	1215
2	Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition Journal of Medicinal Chemistry ·Ute F. Röhrig, Somi Reddy Majjigapu, Aurélien Grosdidier, Lucian Vasilache, Vincent Stroobant, Luc Pilotte, Didier Colau, Pierre Vogel, Benoı̂t J. Van den Eynde, Vincent Zoete, Olivier Michielin	2012	148
3	Identification of Human IKK-2 Inhibitors of Natural Origin (Part I): Modeling of the IKK-2 Kinase Domain, Virtual Screening and Activity Assays PLoS ONE ·Esther Sala, Laura Guasch, Justyna Iwaszkiewicz, Miquel Mulero, M. Josepa Salvadó, Montserrat Pinent, Vincent Zoete, Aurélien Grosdidier, Santiago Garcı́a-Vallvé, Olivier Michielin, Gerard Pujadas	2011	23
4	Fast docking using the CHARMM force field with EADock DSS Journal of Computational Chemistry ·Aurélien Grosdidier, Vincent Zoete, Olivier Michielin	2011	393
5	Identification of human IKK-2 inhibitors of natural origin (Part II): In Silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity European Journal of Medicinal Chemistry ·Esther Sala, Laura Guasch, Justyna Iwaszkiewicz, Miquel Mulero, M. Josepa Salvadó, Cinta Bladé, Ilie Tomulescu, Cristina Valls, Vincent Zoete, Aurélien Grosdidier, Santiago Garcı́a-Vallvé, Olivier Michielin, Gerard Pujadas	2011	20
6	SwissDock, a protein-small molecule docking web service based on EADock DSS Nucleic Acids Research ·Aurélien Grosdidier, Vincent Zoete, Olivier Michielin Hit paper breakdown →	2011	1420
7	SwissParam: A fast force field generation tool for small organic molecules Journal of Computational Chemistry ·Vincent Zoete, Michel A. Cuendet, Aurélien Grosdidier, Olivier Michielin Hit paper breakdown →	2011	1706
8	Use of the FACTS solvation model for protein–ligand docking calculations. Application to EADock Journal of Molecular Recognition ·Vincent Zoete, Aurélien Grosdidier, Michel A. Cuendet, Olivier Michielin	2010	30
9	Docking, virtual high throughput screening and in silico fragment‐based drug design Journal of Cellular and Molecular Medicine ·Vincent Zoete, Aurélien Grosdidier, Olivier Michielin	2009	127
10	Blind docking of 260 protein–ligand complexes with EADock 2.0 Journal of Computational Chemistry ·Aurélien Grosdidier, Vincent Zoete, Olivier Michielin	2009	45
11	Docking to heme proteins Journal of Computational Chemistry ·Ute F. Röhrig, Aurélien Grosdidier, Vincent Zoete, Olivier Michielin	2009	35
12	Local Alignment Refinement Using Structural Assessment PLoS ONE ·D E Bhavana, Aurélien Grosdidier, Ernest Feytmans, Olivier Michielin	2008	4
13	In vitrobiotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1 Biopharmaceutics & Drug Disposition ·Bertrand Rochat, Vincent Zoete, Aurélien Grosdidier, Reena Gupta, 克俊大惠, Olivier Michielin	2008	26
14	Combined Simulation and Mutagenesis Analyses Reveal the Involvement of Key Residues for Peroxisome Proliferator-activated Receptorα Helix 12 Dynamic Behavior Journal of Biological Chemistry ·Liliane Michalik, Vincent Zoete, Grigorios Krey, Aurélien Grosdidier, Laurent Gelman, D E Bhavana, Jérôme N. Feige, Béatrice Desvergne, Walter Wahli, Olivier Michielin	2007	30
15	Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Vincent Zoete, Aurélien Grosdidier, Olivier Michielin	2007	288
16	EADock: Docking of small molecules into protein active sites with a multiobjective evolutionary optimization Proteins Structure Function and Bioinformatics ·Aurélien Grosdidier, Vincent Zoete, Olivier Michielin	2007	156
17	The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor γ Modulator That Promotes Adipogenesis Journal of Biological Chemistry ·Jérôme N. Feige, Laurent Gelman, Daniele Rossi, Vincent Zoete, Raphaël Métivier, Cicerone Tudor, Silvia I. Anghel, Aurélien Grosdidier, H. J. Tucholke, Yves Engelborghs, Olivier Michielin, Walter Wahli, Béatrice Desvergne	2007	293
18	Structural and Functional Interaction Sites between Na,K-ATPase and FXYD Proteins Journal of Biological Chemistry ·Elise Guedin, Aurélien Grosdidier, Gilles Crambert, Jean‐Daniel Horisberger, Olivier Michielin, Käthi Geering	2004	68
19	APDB: a novel measure for benchmarking sequencealignment methods without reference alignments Bioinformatics ·Órla O’Sullivan, Geraldo Valentim Neto, Desmond G. Higgins, Philipp Bücher, Aurélien Grosdidier, Cédric Notredame	2003	40
20	Characterization of the Stromal Cell-derived Factor-1α-Heparin Complex Journal of Biological Chemistry ·Rabia Sadir, Françoise Baleux, Aurélien Grosdidier, Anne Imberty, Hugues Lortat‐Jacob	2001	185

About Aurélien Grosdidier

Aurélien Grosdidier is a scholar working on Biological Psychiatry, Computational Theory and Mathematics, Molecular Biology, Behavioral Neuroscience and Oncology, having authored 23 papers that have together received 6.6k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (9 papers), Protein Structure and Dynamics (8 papers), Enzyme Structure and Function (7 papers), Adipose Tissue and Metabolism (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Glycosylation and Glycoproteins Research (2 papers), Chemical Synthesis and Analysis (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Computational Theory and Mathematics (1.5k citations), Biological Psychiatry (214 citations), Pharmacology (545 citations), Molecular Biology (3.6k citations) and Pharmacology (655 citations). Aurélien Grosdidier has collaborated with scholars based in Switzerland, France and Belgium. Frequent co-authors include Olivier Michielin, Vincent Zoete, Michel A. Cuendet, Matthias Wirth, David Gfeller, Antoine Daina, Hugues Lortat‐Jacob, Anne Imberty, Rabia Sadir and Françoise Baleux. Their work appears in journals such as Journal of Computational Chemistry, Journal of Biological Chemistry, Journal of Medicinal Chemistry, Nucleic Acids Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact